I’d buy these FTSE 100 stocks while share prices are low

With FTSE 100 (INDEXFTSE: UKX) shares prices down significantly this year, many opportunities are emerging for long-term investors.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Every stock market crash provides opportunities for long-term investors. This crash is likely to be no different. With FTSE 100 share prices down significantly this year, many compelling opportunities are emerging.

Of course, in the short term, the FTSE 100 could fall further. No one knows what’s going to happen tomorrow, or next week. However, in the long run, the stock market should recover.

With that in mind, here’s a look at three FTSE 100 stocks I’d snap up while share prices are low.

FTSE 100 champion

One stock I’d buy is Unilever (LSE: ULVR). It’s a consumer goods company that owns a powerful portfolio of trusted brands, including Dove and Domestos.

Unilever appears to be a classic Warren Buffett-type stock. For a start, its brands provide a strong competitive advantage. Secondly, it’s able to generate relatively consistent earnings throughout the economic cycle. Third, it’s highly profitable, generating a return of 20%+ on every euro invested. And finally, it has a superb long-term track record.

ULVR shares have held up well in the recent stock market crash, as I expected. However, I wouldn’t be surprised to see near-term share price weakness if the FTSE 100 falls further. I’d view any such frailty as a buying opportunity.

Healthcare giant

Another FTSE 100 share I’d buy while the market is down is GlaxoSmithKline (LSE: GSK). It’s a healthcare giant that specialises in pharmaceuticals, vaccines, and consumer healthcare products.

The reason I like GSK is that it appears well-placed to benefit from a number of dominant structural trends in the years ahead. Firstly, there’s the world’s ageing population. This is likely to mean increased demand for healthcare. Then, there’s the rise in wealth across the emerging markets. As wealth rises, so does healthcare spending. Finally, there’s the increasing prevalence of diseases, such as chronic obstructive pulmonary disease (the second most common lung disease in the UK after asthma).

I also like the fact that GSK operates in a defensive sector. No matter the state of the economy, people are still likely to need medication and healthcare products.

GSK shares were trading near 1,800p at the start of the year, yet today are significantly cheaper. I’d take advantage of this share price weakness and buy for the long term.

Dominant trend

Finally, another FTSE 100 stock I’d buy while share prices are low is JD Sports Fashion (LSE: JD). I like JD because it’s a play on one of the most dominant trends in the clothing industry today – athleisure.

Throughout the world, demand for the sports casualwear/fitness crossover has skyrocketed in recent years. And this trend looks set to continue. In 2018, the athleisure market was valued at $155bn. Yet by 2026, it’s forecast to be worth $257bn. That’s an annualised growth rate of 7% per year. “The adoption of the athleisure trend is here to stay and it’s going to accelerate,” says Adam Goldenberg, CEO of fashion retailer TechStyle Fashion Group.

Of course, JD’s sales are likely to take a hit in the near term. Its stores are closed, and discretionary income is likely to fall. However, the FTSE 100 company’s share price has fallen a long way this year, meaning a lot of risk is priced in.

Under 500p, I think the stock offers great value.

Edward Sheldon owns shares in Unilever, GlaxoSmithKline and JD Sports Fashion. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline and Unilever. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Two white male workmen working on site at an oil rig
Investing Articles

As oil prices soar, is it time to buy Shell shares?

Christopher Ruane weighs some pros and cons of adding Shell shares to his ISA -- and explains why the oil…

Read more »

Man hanging in the balance over a log at seaside in Scotland
Investing Articles

How much do you need in an ISA for £6,751 passive income a year in 2046?

Let's say an investor wanted a passive income in 20 years' time. How much cash would need be built up…

Read more »

Smiling black woman showing e-ticket on smartphone to white male attendant at airport
Investing Articles

Why isn’t the IAG share price crashing?

Harvey Jones expected the IAG share price to take an absolute beating during current Middle East hostilities. So why is…

Read more »

piggy bank, searching with binoculars
Growth Shares

1 UK share I’d consider buying and 1 I’d run away from on this market dip

In light of the recent stock market dip, Jon Smith outlines the various potential outcomes for a couple of different…

Read more »

Burst your bubble thumbtack and balloon background
Investing Articles

AI may look like a bubble. But what about Rolls-Royce shares?

Bubble talk has been centred on some AI stocks lately. But Christopher Ruane sees risks to Rolls-Royce shares in the…

Read more »

Black woman using smartphone at home, watching stock charts.
Investing Articles

Will the BAE Systems share price soar 13% by this time next year?

BAE Systems' share price continues to surge as the Middle East crisis worsens. Royston Wild asks if the FTSE 100…

Read more »

Portrait of pensive bearded senior looking on screen of laptop sitting at table with coffee cup.
Investing Articles

Is this a once-in-a-decade chance to bag a 9.9% yield from Taylor Wimpey shares?

Taylor Wimpey shares have been hit by a volatile share price and cuts to the dividend. Harvey Jones holds the…

Read more »

Chalkboard representation of risk versus reward on a pair of scales
Investing Articles

Way up – or way down? This FTSE 250 share could go either way

Can this FTSE 250 share turn its fortunes around? Or has its day passed? Our writer looks at both sides…

Read more »